Less drug, more effect


Combining low doses of several cancer drugs at the same time might overcome the important problem of resistance, researchers from the Netherlands Cancer Institute conclude. In the lab this multiple low dose approach shows promising results, they describe in the scientific journal Nature Communications today.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.